Amy Abernethy

Director at Georgiamune.

Raised on Georgiamune filings

$92.7M

of $131.9M offered across 1 Form D filing

Company

Biotech · Gaithersburg, MD

Immune-reprogramming antibodies for cancer and autoimmunity

Immune-reprogramming antibodies for cancer and autoimmunity

Georgiamune Form D filings
Filed	Security	Sold of offered	Filing
Aug 17, 2026	Equity	$92.7M/ $131.9M	Form D

Also named on Georgiamune filings